Melexis NV

MELE: XBRU (BEL)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€221.00RcwcswSnlwgkbkl

Melexis Shares Offer Attractive 40% Upside; Decreasing Our Fair Value Estimate to EUR 100

We believe narrow-moat Melexis shares offer an attractive buying opportunity at this point. Although we are decreasing our fair value estimate to EUR 100 from EUR 105 after adjusting our medium-term forecasts, shares offer 40% upside for long-term investors who are willing to endure a few quarters of uncertainty. Melexis is trading at 13.0 times the 2022 EBIT and 11.3 times the last 12 months' EBIT.

Sponsor Center